This is the first of a series of conferences aimed to gather the leading international experts in the field of oncology.
The three-day conference focuses on sophisticated omics for diagnosis, prognosis and personalized therapy and on personalized use of probiotics and nutraceuticals for complementary and adjuvant therapies. The meeting will consist of selected oral presentations and keynote lectures. Proceedings and full articles will be published in a peer-review journal (Oncology Research or Journal of Molecular Signaling).